Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05110495
Title Windows Trial of INsulin-like Growth Factor Neutralising Antibody Xentuzumab in MEN Scheduled for Radical Prostatectomy (WINGMEN)
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors University of Oxford
Indications

prostate adenocarcinoma

Therapies

Xentuzumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.